Of those with sufficient histologic or PD-L1 TPS information, 55.2% (84/152) were adenocarcinoma, 73.5% (50/68) were PD-L1 TPS < 1% (36.8%, 25/68) or > 50% (36.8%, 25/68). Here, CD274 is linked to adenocarcinoma.